Besides, the antiangiogenesis effects of genistein have been demonstrated in the downregulation of an angiogenic protein, vascular endothelial growth factor (VEGF), in human bladder cancer cells, oral squamous cell carcinoma, and thyroid cancer cells [90,99,100]. Here, VEGFA is linked to oral cavity squamous cell carcinoma.